Our Opinion

Cyclo Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“Hydroxypropyl beta cyclodextrins (HPBCDs) have been found in animal studies to release cholesterol from cells, normalize cholesterol homeostasis, delay symptom onset, and increase lifespan. CTD’s compassionate use program with Trappsol® HPBCD began in 2009, providing significant data which supported the launch of its formal trials.” Read the following article

Company Description

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs.

Company Website: https://cyclotherapeutics.com